| 000 | 01209 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513154830.0 | ||
| 264 | 0 | _c19981204 | |
| 008 | 199812s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(05)60326-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBonelli, R M | |
| 245 | 0 | 0 |
_aReversible Huntington's disease? _h[electronic resource] |
| 260 |
_bLancet (London, England) _cNov 1998 |
||
| 300 |
_a1520-1 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 |
_aAntipsychotic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCaudate Nucleus _xpathology |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aHaloperidol _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHuntington Disease _xdiagnosis |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMianserin _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aKöltringer, P | |
| 700 | 1 | _aKenner, L | |
| 700 | 1 | _aReisecker, F | |
| 700 | 1 | _aBonelli, R | |
| 773 | 0 |
_tLancet (London, England) _gvol. 352 _gno. 9139 _gp. 1520-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(05)60326-1 _zAvailable from publisher's website |
| 999 |
_c9784502 _d9784502 |
||